Shares of USA Technologies (USAT) jumped 20% Thursday after it released its second quarter earnings report. The company booked a gain of 1 cent per share instead of an expected loss of the same magnitude, which triggered an immediate buying frenzy in the stock. Since then it has pulled… Read More
Archive
Filter
Sell the Bristol Myers March $50 Call for a 25% three-week profit Read More
Teradyne (NYSE: TER), a leading maker of semiconductor testing equipment, is less known than other semiconductor sector stocks such as Intel and Texas Instruments. But because every electronic component made needs to be tested, Teradyne plays a central role in the chip sector. Moreover, because demand for its testing products… Read More
I am issuing a buy recommendation for Teradyne (NYSE: TER), a leader in electronic manufacturing equipment testing equipment. Read More
Shares of AMAG Pharmaceuticals (NSDQ: AMAG), a pharmaceutical company focusing on maternal medicine, fell below our Sell Stop of $22 and are now rated SELL. The company’s shares tumbled after it announced positive top line results from its Definitive Pharmacokinetic Study for Makena Subcutaneous Administration and will file a New… Read More
On Jan. 27 I issued a buy recommendation on Synergy Pharmaceuticals (NSDQ: SGYP), a biotech company focusing on diseases and conditions of the digestive system. The company received FDA approval for its idiopathic (cause unknown) constipation drug Trulance on Jan. 19, ten days ahead of the deadline—a bullish sign. … Read More
I am issuing a buy Recommendation on Synergy Pharmaceuticals (NSDQ: SGYP), a biotech company focusing in diseases and conditions of the digestive system. Read More
President Trump wasted no time in increasing the potential for healthcare disruption on his first day in office. Within a few hours of being inaugurated he signed an executive order that gives the heads of federal agencies whose jurisdictions are related to Obamacare what sounds like carte blanche to reshape… Read More
I am recommending the purchase of the Bristol Myers March 17, 2017 Call Option with a $50 strike price. Read More